Patients who bought stockpiles of alternative GLP-1 drugs online aren't sure what to do with them after learning that the compounding pharmacy that made them didn't have the right license.
Copyright 2025 NPR
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.